+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteosarcoma Drug"

From
From
From
Bone Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Bone Cancer Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 367 Pages
  • Global
From
Sarcoma Therapeutics Market 2024-2028 - Product Thumbnail Image

Sarcoma Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 143 Pages
  • Global
From
From
Osteosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Osteosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Osteosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Osteosarcoma is a type of cancer that affects the bones, most commonly found in children and young adults. Oncology drugs are used to treat this type of cancer, and the Osteosarcoma Drug market is a subset of the larger Oncology Drug market. These drugs are used to reduce the size of tumors, reduce pain, and improve quality of life. Treatment options include chemotherapy, radiation therapy, and surgery. The Osteosarcoma Drug market is highly competitive, with many companies developing and marketing drugs to treat this type of cancer. Some of the major players in the market include Pfizer, Novartis, Merck, Bristol-Myers Squibb, and Eli Lilly. Other companies such as Amgen, AstraZeneca, and GlaxoSmithKline are also active in the market. Show Less Read more